SUVEN LIFE SCIENCES LTD. - 530239 - Statement Of Deviation(S) Or Variation(S) For The Quarter Ended 31St March, 2022 Under Regulation 32 Of SEBI (LODR) Regulations, 2015
With reference to the above subject, please find enclosed statement confirming that there were no deviation(s) or variation(s) in the use of proceeds, from the objects for which funds were raised through the preferential issue made by the Company, for the quarter ended 31st March, 2022. SUVEN LIFE SCIENCES LTD. - 530239 - Intimation Of Book Closure & Date Of AGM
Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Member and Share Transfer Books of the Company will remain closed from 02nd August, 2022 to 04th August, 2022 (both days inclusive) for taking record of the Members of the Company for the purpose of 33rd Annual General Meeting of the Company. e-Annual General Meeting (AGM): The 33rd Annual General Meeting of the Company will be held on Thursday, the 04th day of August, 2022 through VC/OAVM. SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Outcome for Outcome Of The Board Meeting
With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. May 07, 2022, approved the following along with other business matters. SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
On the recommendations of Audit Committee, the Board of Directors in its meeting held today i.e. May 07, 2022 has approved the appointment of KARVY & Co., Chartered Accountants as statutory auditors of the Company for a period of five consecutive years from conclusion of ensuing Annual General Meeting till the conclusion of the 38th Annual General Meeting to of the Company which shall be subject to approval of the Members of the Company. SUVEN LIFE SCIENCES LTD. - 530239 - Audited Standalone And Consolidated Financial Results Prepared Under Ind AS For The Quarter And Financial Year Ended 31St March, 2022
1) Took on record and approved the Audited Standalone and Consolidated Financial Results prepared under Ind AS for the quarter and Financial Year ended 31st March, 2022 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Audit Reports of the Statutory Auditors. SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Intimation for Consider And Approve The Audited Financial Results (Standalone And Consolidated) For Financial Year Ended 31St March, 2022
SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2022 ,inter alia, to consider and approve Audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the fourth quarter and year ended 31st March, 2022 and related matters. SUVEN LIFE SCIENCES LTD. - 530239 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompaySUVEN LIFE SCIENCES LTD. 2CINL24110TG1989PLC009713 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: SHRENIK SONI Designation: COMPANY SECRETARY EmailId: shrenik@suven.com Name of the Chief Financial Officer: M Mohan Kumar Designation: Chief Financial Officer EmailId: mohank@suven.com Date: 25/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. SUVEN LIFE SCIENCES LTD. - 530239 - Submission Of Compliance Certificate Under Regulation 40(10) For The Year Ended 31St March, 2022.
With reference to above subject, please find enclosed Compliance Certificate for the year ended 31st March, 2022 issued by the Practicing Company Secretary, under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. SUVEN LIFE SCIENCES LTD. - 530239 - Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For Year Ended 31St March, 2022
With reference to the above subject, please find enclosed Compliance Certificate for the year ended 31st March, 2022 duly signed by the Compliance Officer and authorized representative of the Share Transfer Agent i.e. KFin Technologies Limited, Hyderabad, under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.